Trial Profile

Effect of Armodafinil on Simulated Driving, Electroencephalogram and Cognitive Performance in Sleep Deprived Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Armodafinil (Primary)
Indications Eating disorders; Fatigue; Hypersomnia
Focus Pharmacokinetics; Therapeutic Use

Most Recent Events

01 Sep 2018 Results assessing the effect of armodafinil on neurocognitive tests, driving performance and electroencephalogram, published in the Clinical Pharmacology in Drug Development: 2018 Annual Meeting of the American College of Clinical Pharmacology.
30 Nov 2017 Status changed from recruiting to completed.
23 May 2017 Planned End Date changed from 1 Jul 2017 to 31 Dec 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com